Access to Breast Cancer Diagnosis Act of 2025

The Access to Breast Cancer Diagnosis Act of 2025 would prohibit group health plans and health insurance issuers from imposing cost-sharing requirements—such as deductibles, copayments, or coinsurance—for diagnostic and supplemental breast examinations. It applies to individuals enrolled in group or individual health insurance coverage and ensures these medically necessary exams, as defined by National Comprehensive Cancer Network Guidelines, are covered without out-of-pocket costs. The bill also clarifies that plans may still use prior authorization or utilization controls and preserves stronger state laws, while extending the prohibition to grandfathered plans and high-deductible health…

No official summary is available here. This one was written by AI from the bill’s text.